Health
4 Reasons to Hang On to Your Moderna Stock – Motley Fool
A proposal to nullify intellectual property regarding COVID-19 vaccines seems unlikely to affect Moderna’s bottom line.
Shares of Moderna(NASDAQ:MRNA) and its peers have been under pressure in response to a bomb the Biden administration’s new trade envoy, Katherine Tai, dropped on America’s technology-driven economy. On May 5, Tai voiced support for a World Trade Organization (WTO) proposal that would nullify intellectual property rights in COVID-19 vaccines for Moderna and its peers.
Fortunately for Moderna, the U.S. trade envoy’s position is based on arguments that don’t hold water. Here are four reasons the WTO’s…
-
Business5 hours ago1 ASX dividend stock down 43% I’d buy right now
-
General23 hours agoFederal Labor makes $100m Canberra convention centre funding pledge for planning, new aquatic centre
-
General15 hours agoCoalition abandons ‘end’ to work from home, walks back 41,000 job cuts
-
General21 hours agoSector warns Coalition’s plan to limit overseas students ‘straight out of Trump’s playbook’